Ballicules.com

Sotalol and Formoterol: a Beta-2 adrenergic receptor interaction

Sotalol blocks the beta-2 adrenergic receptor, so Formoterol cannot act there — the effect of Formoterol is reduced or lost.

Formoterol is an agonist at the beta-2 adrenergic receptor: it binds and switches the receptor on. Sotalol is an antagonist at the same site and switches nothing on. With both present they compete for the same pocket, and whichever is there in greater effective concentration decides what the receptor does.

Given together they work against whatever each was started for. If both are genuinely needed, expect less of Formoterol’s effect than its dose would suggest.

This is a pharmacodynamic interaction. Neither drug changes the other’s concentration, so a level, an AUC estimate or a genotype looks entirely normal while the clinical effect is blunted.

The direction can be the useful one. The same opposition is what makes a reversal agent, an antidote or a planned antagonist work.

Sotalol versus Formoterol over the Beta-2 adrenergic receptor
Fight club: Sotalol versus Formoterol — Beta-2 adrenergic receptor

The two ballicules, with the Beta-2 adrenergic receptor lit on each

Sotalol ballicule, with its Beta-2 adrenergic receptor peg ringed
Sotalol (BETAPACE)
Beta-2 adrenergic receptor antagonist
Formoterol ballicule, with its Beta-2 adrenergic receptor peg ringed
Formoterol (FORADIL)
Beta-2 adrenergic receptor agonist

The ring marks the peg each drug wears for this receptor — the same cross-illumination Interact! draws when the two are put side by side.

The mascots

Sotalol mascot mnemonic cartoon
Sotalol
Better pace (yourself), Soda, LOL
Formoterol mascot mnemonic cartoon
Formoterol
Formal aerosol

Open it in the console